— Know what they know.
Not Investment Advice

TWST

Twist Bioscience Corporation
1W: +9.4% 1M: +0.2% 3M: +38.7% YTD: +50.2% 1Y: +8.2% 3Y: +194.4% 5Y: -60.9%
$48.64
+1.15 (+2.42%)
After Hours: $48.45 (-0.19, -0.38%)
NASDAQ · Healthcare · Medical - Diagnostics & Research · $3.0B · Alpha Radar Neutral · Power 46
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$3.0B
52W Range23.3-57.88
Volume1,905,541
Avg Volume1,271,620
Beta2.29
Dividend
Analyst Ratings
10 Buy 2 Hold 1 Sell
Consensus Buy
Company Info
CEOEmily Marine Leproust
Employees923
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2018-10-31
681 Gateway Boulevard
South San Francisco, CA 94080
US
800 719 0671
About Twist Bioscience Corporation

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.

Recent Insider Trades

NameTypeSharesPriceDate
Cho Dennis S-Sale 354 $43.79 2026-03-20
Green Paula S-Sale 297 $43.79 2026-03-20
Leproust Emily M. S-Sale 1,742 $43.79 2026-03-20
CHESS ROBERT M-Exempt 10,000 $11.89 2026-03-17
CHESS ROBERT S-Sale 10,000 $47.00 2026-03-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms